Viewing Study NCT05110027


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-02-06 @ 3:52 AM
Study NCT ID: NCT05110027
Status: COMPLETED
Last Update Posted: 2022-04-04
First Post: 2021-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Enpatoran Human Mass Balance and Absolute Bioavailability Study
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Microtracer View
None Microdose View
None Clinical Pharmacology View